| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.89 | $53.22 (0%) | 🛒 Add to cart |
| 90 | $0.81 | $79.82 $73.30 (8%) | 🛒 Add to cart |
| 120 | $0.78 | $106.43 $93.38 (12%) | 🛒 Add to cart |
| 180 | $0.75 | $159.65 $134.55 (16%) | 🛒 Add to cart |
| 270 | $0.72 | $239.47 $194.79 (19%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $319.30 $255.03 (20%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Trazodone: Restore Restful Sleep and Mood Balance
Trazodone is an FDA-approved antidepressant medication belonging to the serotonin antagonist and reuptake inhibitor (SARI) class, widely prescribed for its dual efficacy in managing major depressive disorder and insomnia. Its unique pharmacological profile promotes serotonin activity while mitigating common activating side effects associated with traditional SSRIs, making it a versatile option in psychiatric and sleep medicine. Clinicians value trazodone for its favorable side effect profile, low abuse potential, and utility in both acute and maintenance therapy.
Desyrel: Restore Restful Sleep and Emotional Balance
Desyrel (trazodone hydrochloride) is a prescription medication classified as a serotonin antagonist and reuptake inhibitor (SARI), primarily indicated for the treatment of major depressive disorder (MDD). Its unique pharmacological profile not only addresses core depressive symptoms but is also widely utilized off-label for the management of insomnia, particularly where sleep initiation and maintenance are concerns. By modulating serotonin activity in the central nervous system, Desyrel helps correct the chemical imbalances often associated with mood and sleep disorders, offering a dual therapeutic approach for suitable patients.
EMSAM: A Transdermal MAOI for Treatment-Resistant Depression
EMSAM (selegiline transdermal system) is a monoamine oxidase inhibitor (MAOI) delivered through a transdermal patch, offering a novel mechanism of action for adults with major depressive disorder (MDD) who have not achieved an adequate response from other antidepressant therapies. By bypassing first-pass metabolism, EMSAM provides targeted delivery of selegiline, a potent and irreversible inhibitor of monoamine oxidase, while potentially mitigating the need for the strict dietary tyramine restrictions historically associated with oral MAOIs at its lowest dosage.
Abana: Natural Cardiovascular Support for Optimal Heart Health
Abana is a clinically studied, natural supplement formulated to support cardiovascular wellness and maintain healthy cholesterol levels already within the normal range. Developed through extensive research in Ayurvedic medicine, this proprietary blend combines potent botanicals and minerals known for their cardioprotective properties. Abana works holistically to promote circulatory function, support lipid metabolism, and provide antioxidant protection against oxidative stress. Its multi-mechanism approach makes it an ideal choice for individuals seeking comprehensive cardiovascular maintenance through evidence-based natural medicine.
Abhigra: Advanced Relief for Chronic Inflammatory Conditions
Abhigra represents a significant advancement in targeted anti-inflammatory therapy, engineered for patients with persistent inflammatory disorders who have found inadequate relief from conventional treatments. Developed through rigorous clinical research, this prescription medication employs a sophisticated mechanism of action to modulate inflammatory pathways at the cellular level, offering a new standard in both efficacy and tolerability. Its precision-targeted formulation minimizes systemic exposure while maximizing therapeutic impact at affected sites, making it a preferred option among rheumatologists, gastroenterologists, and dermatologists specializing in autoimmune and chronic inflammatory diseases.
Abilify: Atypical Antipsychotic for Symptom Control and Stability
Abilify (aripiprazole) is an atypical antipsychotic medication approved for the treatment of several psychiatric conditions, including schizophrenia, bipolar disorder, and as an adjunctive treatment for major depressive disorder. It functions as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at serotonin 5-HT2A receptors, which contributes to its unique efficacy and tolerability profile. This mechanism helps stabilize dopamine and serotonin activity in the brain, reducing symptoms such as hallucinations, delusions, and mood swings while minimizing certain side effects commonly associated with first-generation antipsychotics.
Acamprol: Clinically Proven Relief for Alcohol Dependence
Acamprol (acamprosate calcium) is a prescription medication specifically developed to support maintenance of abstinence in alcohol-dependent patients. It functions by modulating neurotransmitter systems disrupted by chronic alcohol consumption, particularly glutamatergic hyperactivity, thereby reducing the psychological distress associated with alcohol withdrawal and craving. This pharmacological agent is indicated as part of a comprehensive management program that includes psychosocial support. Its delayed-release tablet formulation ensures consistent plasma concentrations, supporting long-term therapy adherence. Clinical trials and post-marketing surveillance have established its efficacy and safety profile in diverse patient populations.
Accufine: Precision-Engineered Relief for Chronic Neuropathic Pain
Accufine represents a significant advancement in the pharmacological management of moderate to severe chronic neuropathic pain. This prescription medication, containing the active ingredient Pregabalin, is specifically formulated to modulate hyperexcited neurons, providing targeted relief where traditional analgesics often fall short. Its development is grounded in robust clinical research, offering a reliable option for clinicians seeking to improve quality of life for patients suffering from debilitating nerve pain conditions. By specifically targeting the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, Accufine reduces the release of several neurotransmitters, thereby diminishing pain signals and associated symptoms.
Accupril: Effective Blood Pressure Control for Cardiovascular Health
Accupril (quinapril hydrochloride) is an angiotensin-converting enzyme (ACE) inhibitor prescription medication specifically formulated for the management of hypertension and heart failure. As a trusted therapeutic option in cardiovascular medicine, it works by relaxing blood vessels to allow blood to flow more smoothly, thereby reducing the heart’s workload. This medication represents a cornerstone treatment in modern cardiology practice, offering both efficacy and a well-established safety profile when administered under proper medical supervision.